臨床醫學研究所

Medicine & Life Sciences

1. Neoplasms 80%
2. interleukin 20 57%
3. Pancreatic Neoplasms 46%
4. Survival 41%
5. Therapeutics 41%
6. Lung Neoplasms 40%
7. Peroxisome Proliferator-Activated Receptors 35%
8. Stomach Neoplasms 33%
9. Inflammation 32%
10. Genes 31%
11. Adenocarcinoma of Lung 31%
12. Phosphorylation 31%
13. Adenocarcinoma 30%
14. Proteins 29%
15. gemcitabine 29%
16. Growth 28%
17. Mutation 28%
18. Cohort Studies 26%
19. Pancreaticoduodenectomy 24%
20. Solitary Nucleus 24%
21. Population 23%
22. Non-Small Cell Lung Carcinoma 23%
23. Cytokines 23%
24. Alzheimer Disease 22%
25. Phosphatidylinositol 3-Kinase 22%
26. Wounds and Injuries 21%
27. MicroRNAs 21%
28. Glycogen Synthase Kinase 3 21%
29. Biomarkers 20%
30. Schizophrenia 20%
31. Catenins 20%
32. Kidney 19%
33. Cell Line 19%
34. Stroke 18%
35. Drug Therapy 18%
36. Hypertension 18%
37. Reactive Oxygen Species 18%
38. Liver 18%
39. Skin 18%
40. Incidence 17%
41. In Vitro Techniques 17%
42. Obesity 17%
43. Insulin Resistance 17%
44. Down-Regulation 17%
45. Acute Coronary Syndrome 17%
46. Irinotecan 17%
47. Fluorouracil 16%
48. Hydroxymethylglutaryl-CoA Reductase Inhibitors 16%
49. Macrophages 16%
50. Insulin 16%
51. Carcinoma 16%
52. Stem Cells 16%
53. Confidence Intervals 16%
54. Gastropoda 16%
55. Safety 16%
56. Leucovorin 15%
57. Cell Movement 15%
58. Lung 15%
59. Gastrointestinal Stromal Tumors 15%
60. Mortality 14%
61. Hepatocellular Carcinoma 14%
62. Osteopontin 14%
63. quinoline 14%
64. Mouth Neoplasms 14%
65. Blood Pressure 14%
66. Brain 14%
67. Carcinogenesis 14%
68. Neurons 13%
69. Protein-Tyrosine Kinases 13%
70. Stomach 13%
71. Phosphatidylinositols 13%
72. collapsin response mediator protein-1 13%
73. Infections 13%
74. ErbB Receptors 13%
75. phosphatidylinositol 3,4,5-triphosphate 13%
76. Endothelial Cells 12%
77. Interleukin-1 12%
78. Interleukins 12%
79. Tuberculosis 12%
80. Chronic Renal Insufficiency 12%
81. Cardiac Myocytes 12%
82. Esophageal Squamous Cell Carcinoma 12%
83. Serum 12%
84. Ligation 12%
85. Messenger RNA 12%
86. Myocardial Infarction 12%
87. Retrospective Studies 12%
88. Regeneration 12%
89. Monoclonal Antibodies 12%